68 results
Page 2 of 4
8-K
EX-99.1
iibsseoc8 f8
9 Aug 21
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:27pm
8-K
3hkgtd7a 3a41
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
8-K
EX-99.1
99xkpnwfx93cumfgnl
14 Jun 21
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
4:22pm
8-K
EX-99.1
743 cozrj2wo675a
25 Feb 21
Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update
8:00am
8-K
EX-99.1
9pe23h 9m
10 Nov 20
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update
4:14pm
8-K
EX-99.1
lg8056l07gz0z0su7a8
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
mr7b6jfvw6s2zyj
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.2
0bvwnzlh10tbt
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
424B5
fcxsxek wpxit8v
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
haq3 5x64s0dxf
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
ealtslv
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
xdr5ccd73noinyi
18 May 20
Prospectus supplement for primary offering
4:11pm